Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients

Inclusion Criteria: * Subject has the ability to understand and sign the informed consent document * Subject is 18 years of age or older * Subject can be male or female * Subject has negative Purified Protein Derivative (Tuberculosis skin test) or quantiferon TB Gold Test (blood test for TB) testing done in 3 months * Subject has active ocular inflammation in at least one eye * Subject has visual acuity in at least one eye of 20/400 or better. * Subject has a history of glaucoma or has actively treated glaucoma * Subject is willing and able to comply with the study procedures * Female subjects of childbearing potential must not be pregnant or breast-feeding, must have a negative pregnancy test at screening and must be willing to undergo pregnancy testing throughout the study Exclusion Criteria: * Subject has any ocular infection * Subject has any systemic infection * Participant has documented immunocompromised or immune-incompetent state * Subject has any ocular co-morbidity than prevents assessment of intraocular inflammation * Subject has had any intra-ocular surgery in previous 6 weeks * Subject has any planned elective surgery ocular or systemic during study duration * Subject is pregnant or breast-feeding * Subject had a recent vaccination with live or attenuated vaccines * Subject has a sensitivity to Porcine derived proteins * Subject has a medical history which is a contraindication to receiving H.P. Acthar